MBX
MBX Biosciences Inc.
$39.41
+$0.34(+0.87%)
65
Overall
60
Value
91
Tech
44
Quality
Market Cap
$34.31M
Volume
2.60M
52W Range
$4.81 - $44.89
Target Price
$61.10
Company Overview
| Mkt Cap | $34.31M | Price | $39.41 |
| Volume | 2.60M | Change | +0.87% |
| P/E Ratio | -0.6 | Open | $39.20 |
| Revenue | -- | Prev Close | $39.07 |
| Net Income | $-61.9M | 52W Range | $4.81 - $44.89 |
| Div Yield | N/A | Target | $61.10 |
| Overall | 65 | Value | 60 |
| Quality | 44 | Technical | 91 |
No chart data available
Latest News
MBX Biosciences Appoints Laurie Stelzer to Board, Audit Chair
TipRanks Auto-Generated Newsdesk•13 days ago
Analysts Offer Insights on Healthcare Companies: MBX Biosciences, Inc. (MBX), Teladoc (TDOC) and Pfizer (PFE)
Brian Anderson•19 days ago
MBX Biosciences, Inc. (MBX) Receives a Buy from Stifel Nicolaus
TipRanks Auto-Generated Intelligence Newsdesk•22 days ago
MBX Biosciences Highlights 2026 Outlook and Pipeline Progress
TipRanks Auto-Generated Newsdesk•23 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MBX | $39.41 | +0.9% | 2.60M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |